Học tiếng Anh hiệu quả, nhanh chóng: http://www.facebook.com/HocTiengAnhVOA, http://www.voatiengviet.com/section/hoc-tieng-anh/2693.html. Nếu không vào được VOA, xin hãy vào http://vn3000.com để vượt tường lửa. Các chương trình học tiếng Anh miễn phí của VOA (VOA Learning English for Vietnamese) có thể giúp bạn cải tiến kỹ năng nghe và phát âm, hiểu rõ cấu trúc ngữ pháp, và sử dụng Anh ngữ một cách chính xác. Xem thêm: http://www.facebook.com/VOATiengViet
Luyện nghe nói và học từ vựng tiếng Anh qua video. Xem các bài học kế tiếp: https://www.youtube.com/playlist?list=PLD7C5CB40C5FF0531
Health: Luyện nghe nói tiếng Anh qua video: Chương trình học tiếng Anh của VOA: Special English Health Report. Xin hãy vào http://www.voatiengviet.com/section/hoc-tieng-anh/2693.html để xem các bài kế tiếp.
A top health expert warns that the world needs to deal with what he calls the “first Ebola epidemic the world has known.” Tom Frieden, director of the U.S. Centers for Disease Control spoke to reporters at the C.D.C. headquarters in Atlanta, Georgia. He warned that the Ebola outbreak in West Africa could spread widely. He said a huge global effort is needed to contain the disease. Dr. Frieden just returned from a visit to the most affected countries: Sierra Leone, Guinea and Liberia. He said Ebola cases continue to increase quickly even though health care workers are working extremely hard against the spread. News reports say the number of cases is more than 5,000. Dr. Frieden warned that there is a window of opportunity to stop Ebola. But he added that window is closing. The C.D.C. chief said the Ebola virus is spreading in two ways: from patients to care givers and through unsafe treatment of the dead. Dr. Frieden warned that each day’s delay in dealing with the Ebola spread makes it more difficult to stop. The C.D.C. director said resources, technical experts and a worldwide, organized and unified plan are needed. He said Ebola is not only an African problem, but a world problem. U.S. health officials have announced an agreement with a California-based drugmaker, Mapp Biopharmaceuticals. The deal calls for the company to speed development of the experimental Ebola medicine ZMapp. ZMapp has not been tested on humans. But, two American medical missionaries who had Ebola were treated with the drug and recovered.
